Navigation Links
TetraLogic Pharmaceuticals Announces Presentation of Data on Smac Mimetic TL32711 at AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics
Date:11/13/2011

MALVERN, Pa., Nov. 13, 2011 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced presentations of new data on its Smac mimetic drug candidate TL32711 at the 2011 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics in San Francisco. TL32711 is nearing completion of a single agent Phase 1 study in solid tumors and lymphomas and a Phase 1b five-arm combination clinical study in solid tumors.

In a poster entitled "Phase 1 PK/PD Analysis of the Smac Mimetic TL32711 Demonstrates Potent and Sustained cIAP1 Suppression in Patient PBMC and Tumor Biopsies" (Abstract # A25), the degradation and suppression of cIAP1 was analyzed as part of the single agent Phase 1 study. The data demonstrated that TL32711 causes potent and sustained suppression of inhibitor of apoptosis protein cIAP1 in patient peripheral blood mononuclear cells (PBMCs) and tumor biopsies over 7 days at tolerable dose levels with evidence of apoptosis pathway activation and promising early signs of anti-tumor activity in patients.

In a poster entitled "Dose scheduling and efficacy analysis of the Smac mimetic TL32711 in primary melanoma tumor xenotransplant models" (Abstract # A225), tumor growth inhibition was observed in primary melanoma tumor xenografts following treatment with single agent TL32711.  Combining TL32711 with carboplatin and paclitaxel resulted in a further enhancement in anti-tumor efficacy with tumor regressions without any marked changes in tolerability.

About TL32711

TL32711 is a small molecule peptidomimetic of Smac (Second mitochondrial-derived activator of caspases) an endogenous regulator of apoptotic cell death that selectively antagonizes multiple IAPs. TL32711 has demonstrated preclinical anti-tumor a
'/>"/>

SOURCE TetraLogic Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. TetraLogic Closes $23 Million Second Tranche of Series C Financing
2. TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd.
3. TetraLogic Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 Actavis plc (NYSE: ACT ... , Chief Communications Officer, will retire from Actavis ... conjunction with Mayr,s retirement, Alex Kelly , ... Chief Communications Officer, effective immediately. Prior to joining ... President, Chief Communications Officer, Public Affairs and Investor ...
(Date:4/20/2015)... BILLERICA, Mass. , April 20, 2015 /PRNewswire/ ... tools for cell metabolism research, introduces the XFp ... a unique real-time assay on live cells that ... one-hour test measures both the mitochondrial and glycolytic ... values with metabolic activity under stressed conditions, induced ...
(Date:4/20/2015)... 2015 This report analyzes the worldwide markets for ... the following Product Segments: Sphygmomanometers (Aneroid Sphygmomanometers, & Digital Sphygmomanometers), ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for the period ...
Breaking Medicine Technology:Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3New XFp Cell Energy Phenotype Test Determines Metabolic Potential 2New XFp Cell Energy Phenotype Test Determines Metabolic Potential 3World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28
... WIRE)--May 14, 2007 - Oculus Innovative,Sciences, Inc. ... the subject of a poster presentation at ... was held in,Glasgow, Scotland this past week., ... Antimicrobial,Solution in the Treatment of Infected Chronic ...
... Symptom Severity; New,Resources for Patients, Parents, WASHINGTON, May ... by the National Consumers League shows that American,asthma ... Four in,ten asthma sufferers understand asthma medication categories,somewhat ... the diagnosis, the less,knowledgeable adult patients tend to ...
Cached Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3New Survey Finds Troubling Data on American Asthma Sufferers 2New Survey Finds Troubling Data on American Asthma Sufferers 3New Survey Finds Troubling Data on American Asthma Sufferers 4New Survey Finds Troubling Data on American Asthma Sufferers 5New Survey Finds Troubling Data on American Asthma Sufferers 6
(Date:4/21/2015)... Timonium, Maryland (PRWEB) April 21, 2015 eSight ... who are legally blind to see and, on Tuesday, May ... (LVS of MD & VA) will host an unveiling ... Timonium, MD office. LVS of MD & VA will be ... eyewear. A limited number of individual patient demonstrations will be ...
(Date:4/21/2015)... April 21, 2015 Bulk food-grade ... 3.8 out of 5, indicating generally favorable purchasing conditions ... low barriers to entry and the fact that most ... relatively short distances,” says IBISWorld research analyst Hayden Shipp. ... country, typically serving local and regional markets.” Suppliers include ...
(Date:4/21/2015)... San Antonio, TX (PRWEB) April 21, 2015 ... reconstruction, PRMA is actively involved in various components ... basic science fields. , "Breast reconstruction ... outcomes following mastectomy. Despite recent advances, many ... order to provide patients with optimal results," says ...
(Date:4/21/2015)... The Northeast Football Clinic (NEFC) has ... prep school in Byfield, MA. Applications are being accepted ... entering grades 6-12. , The outstanding professional, college, and ... coaching. , Offensive and defensive linemen and ... the most unsung positions on the field, the the ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 ... solutions for biopharmaceutical development, today announced that the ... the University of Ottawa has acquired a Freeslate ... Screening Pressure Reactor (SPR) to accelerate current ... High-Throughput Experimentation Facility where they will be available to ...
Breaking Medicine News(10 mins):Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 3Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3
... report in The Journal of the American Medical Association. ... levels with a diet supplement of folic acid alone ... University of California at San Francisco and colleagues used ... cost effectiveness of lowering levels of homocystine through grains ...
... segment with its "Smoquit" (buproprion 150mg tabs) recently. The ... decade as an antidepressant, albeit at a different dose. ... ever available for the treatment of smoking problem, is ... under medical supervision and guidance. // ,Smoking ...
... compare digital mammography with the standard technique to confirm ... more accuracy. Standard film mammography has been around for ... the scope and limitations of the technology.// ,Digital ... with dense breast tissue, because it offers higher contrast. ...
... who drink in moderation – between one and seven ... than either abstainers or heavier drinkers who consume more ... ,Dr Kenneth Mukamal and colleagues at Beth Israel ... consumption among elderly patients appeared to protect against age-related ...
... a cardiac arrest and are easier to use. Nearly ... year in the United States.// Many lives could be saved ... an automated electrical defibrillator (AED), a device which delivers an ... put more AED's in public places, like shopping malls, and ...
... developing cataracts, scientists have found. A cataract is a cloudy ... eye.As the opacity thickens, it prevents light rays from passing ... sensitive tissue lining the back of the eye. It is ... who were exposed to high levels of sunlight, or solar ...
Cached Medicine News:
... Already, the most advanced motor driven refractor, ... and faster to learn and operate. Specialized ... accuracy and precision. Our software makes operating ... transition from manual instruments or other automated ...
... Medmont AT20R places fast and ... your fingertips. Utilising standard computer ... PC environment with new testing ... is easily integrated into a ...
... The first Open Bore MR ,Siemens has ... 70 cm bore, a very short 125 cm ... create something very revolutionary: Open Bore MR. And ... imaging matrix). A unique Siemens technology, which means ...
... laser-cut stent, is the latest in a ... use after coronary arteries have been opened ... as percutaneous transluminal coronary angioplasty (PTCA). The ... features designed to optimize scaffolding, radiopacity and ...
Medicine Products: